Company Overview
Beneficient operates as a technology-enabled financial services company that provides liquidity solutions alongside trustee, custody, and trust administrative services to participants within the alternative asset industry across the United States. The firm functions within the Financial Services sector, specifically targeting the Asset Management industry, which implies a specialized role in facilitating the movement and administration of capital for alternative investment vehicles. Beneficient currently maintains a market capitalization of $46.11M and employs a workforce of 55 individuals to execute its operational model. The combination of a market cap of $46.11M and annual revenue of -$27,685,000 suggests a small-cap entity with a negative revenue baseline, indicating that the company's top-line financial performance is currently in a deficit state relative to its operational scale.
Financial Health
The company reported revenue of -$27,685,000 over the trailing twelve months, with net income standing at -$86,100,000 and EBITDA at -$71,480,000. The significant divergence between the negative revenue figure of -$27,685,000 and the substantially larger net loss of -$86,100,000 reveals a cost structure where operating expenses and other deductions far exceed the reported top-line metric, resulting in a net loss that is more than three times the magnitude of the revenue deficit. Free cash flow is recorded at -$16,069,000, which indicates that the company is consuming cash rather than generating liquidity from its operations, thereby limiting its financial flexibility and requiring reliance on existing cash reserves or external financing. Gross margin is 0.0%, operating margin is 52.2%, and profit margin is 0.0%; the zero gross and profit margins coupled with a positive operating margin of 52.2% suggest a complex accounting structure where revenue recognition or cost of goods sold treatment results in zero gross profitability, yet operating expenses are managed such that the operating margin calculation yields a positive figure despite the overall net loss. Total cash on hand amounts to $7.87M, while total debt sits at $100.34M, creating a situation where liabilities significantly exceed liquid assets; the debt-to-equity ratio is listed as N/A, which prevents a direct leverage calculation but implies that the equity base may be eroded to such an extent that traditional leverage metrics are not applicable or meaningful in standard analysis. The current ratio is 0.27, a figure that indicates the company possesses less than one-third of the current assets necessary to cover its current liabilities, signaling potential short-term liquidity constraints. Return on equity stands at -447.2% and return on assets is -12.0%, metrics that reveal management effectiveness is currently negative, as the company is destroying value relative to both the shareholders' equity and the total asset base employed.
Valuation Assessment
The trailing P/E ratio is N/A due to the negative earnings, while the forward P/E is 0.53; the disparity between a non-existent trailing multiple and a low forward multiple of 0.53 implies that the market is pricing in a normalization of earnings or a significant turnaround in profitability for the upcoming period. The price-to-book ratio is -0.25, a negative multiple that indicates the market value of the company trades at a discount relative to its book value, suggesting the stock is priced below the accounting value of its assets or reflecting significant concerns regarding asset quality and solvency. The price-to-sales ratio is -1.67 and the EV/EBITDA is -3.91; these alternative valuation metrics present negative multiples because the company is generating negative earnings and negative cash flows, which renders traditional valuation frameworks difficult to apply without significant adjustments for non-recurring items or structural changes. The 52-week high is $12.48 and the 52-week low is $1.75; without a specific current price provided in the facts, the valuation range indicates a wide trading band of $10.73, spanning from the low of $1.75 to the high of $12.48, which reflects high historical volatility. The beta is 1.09, meaning the stock's price volatility is slightly higher than the broader market, as a beta greater than 1.0 suggests that the asset will tend to move more aggressively than the market index during periods of increased volatility.
Growth & Income
Revenue growth year-over-year is 322.5%, while earnings growth is N/A; the presence of revenue growth combined with the absence of earnings growth data implies that the increase in revenue has not yet translated into profitability, likely due to the high fixed costs or the negative net income structure persisting despite the top-line expansion. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%; consequently, the firm reinvests its limited earnings or cash flow back into the business rather than distributing returns to shareholders. The overall growth and income profile is characterized by a dramatic revenue expansion of 322.5% that has not yet resulted in positive earnings, coupled with a complete absence of dividend income for investors seeking current yield.